The national government has so far secured two official deals for COVID-19 vaccine supplies in the Philippines, one with Chinese pharmaceutical company Sinovac and another with the Serum Institute of India.
Watch this space for bite-sized developments on the vaccines in the Philippines. (Main image by Markus Spiske via Unsplash)
Muntinlupa resumes first dose vaccination using AstraZeneca; second dose jabs at 70K mb.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mb.com.ph Daily Mail and Mail on Sunday newspapers.
Vaccination in Taguig (Taguig City government)
In an announcement Saturday, the city government said, “The administration of Sinovac second doses on Monday, July 12, 2021, will be deferred to a later date. We assure everyone that Sinovac second doses may still be given beyond the date indicated on your vaccination cards.”
“The Department of Health has determined that the administration of second doses of COVID-19 vaccines is acceptable 3 to 6 months after administration of the first dose,” it added.
Last July 7, Taguig suspended the first dose vaccination using Sinovac for two weeks due to lack of new supply.
It cited Advisory No. 62 dated July 4 issued by Sec. Carlito Galvez Jr. and Sec. Vince Dizon of the National Task Force Against COVID-19, which advised local government units (LGUs) and local vaccination operation centers (LVOCs) about the delay in the arrival of Sinovac and Sputnik V vaccines in the country.
SunStar
(File) May 07, 2021 THE Department of Health (DOH) on Friday, May 7, 2021, announced the resumption of vaccinations using the Oxford AstraZeneca vaccine ahead of the expected delivery of two million doses within the month.
The agency said guidelines on the management of adverse events following immunization (AEFI), particularly for the very rare vaccine-induced thrombosis and thrombocytopenia (VITT), have been updated.
VITT is a very rare condition of blood clots associated with low platelet counts that can occur 4 to 28 days after receiving a viral vector vaccine such as AstraZeneca, DOH said in a statement Friday.
Vaccinations using the AstraZeneca vaccine were halted for individuals below 60 years old on April 8 because of recent reports of very rare cases of blood clots.
DOH resumes use of AstraZeneca vaccines for all age groups
THE DEPARTMENT of Health (DOH) has reallowed the use of the Oxford AstraZeneca vaccine for all age groups.
In a statement on Friday, the DOH said based on the recommendation of the Food and Drug Administration (FDA) and the DOH All Experts Group on Vaccines (DOH-AEGV), it was concluded that there are currently “no known risk factors” for vaccine-induced thrombosis and thrombocytopenia (VITT) a very rare condition of blood clots associated with low platelet counts that occur four to 28 days after receiving a viral vector vaccine such as AstraZeneca.
It noted that the benefits of receiving the vaccine “still outweigh the risk”.